Skip to main content

The Brainclinics Foundation

Applied Neuroscience from the clinic,to the clinic

Research Institute Brainclinics was founded in 2001 as an independent research institute and specializes in advancing our understanding of the brain; applied neuroscience to improve treatments for ADHD, Depression and OCD.  The results of our research are a valuable aid in the treatment and prevention of symptoms such as mood-, concentration-, impulse control-, and sleep-problems, often seen in disorders such as depression, ADHD, and insomnia. Our expertise extends to the development and application of brain stimulation techniques, such as rTMS for depression and OCD, TMS induced Heart-Brain Coupling and EEG based precision psychiatry and stratified psychiatry for Depression and ADHD.

Masterclass

Our TMS Masterclass & Certification course takes you from the basics of TMS and Brain Stimulation, to exciting new developments in this field with world renown speakers from all over the...

Resources

Get access to our Brainclinics resources, such as books, theses and the open access TDBRAIN EEG dataset with more than 1200 EEG’s and descriptive data.

Research

Read more about our scientific publications and articles over the years.

Citations

9996

Publications

255

Co-authors

765

News

We regularly post news on Linkedin. Please follow us on Linkedin to get the latest news in your Linkedin feed. 

25 January 2025
Large piece in Dutch newspaper on use of Brainmarker-I (alpha frequency based EEG biomarker) in clinical practice. Congrats Nikita van der Vinne and Synaeda. See links in comments below re further scientific backgrounds and validation studies. https://lnkd.in/eefsXeqc
25 January 2025
Bij een Friese ggz-instelling krijgen patiënten met een depressie medicatie voorgeschreven op basis van hersenonderzoek. ‘Onze werkwijze is geen wondermiddel’, zegt gezondheidszorgpsycholoog Nikita van der Vinne. ‘Wij kunnen niet met zekerheid voorspellen welk middel voor jou werkt. Wat we wel kunnen zien is bij welk middel de kans groter is dat het aanslaat.’ Lees meer via deze link: https://lnkd.in/dJgFY5iE
25 January 2025
Congrats Synaeda and Nikita van der Vinne, great to see a good piece on Brainmarker-I use in Depression in one of the major newspapers! And that's only on stratification between antidepressants, not even including stratification between TMS protocols!
28 December 2024
TMS is cost-effective for treatment resistant depression relative to the next pharmacological treatment step. Congrats Iris Dalhuisen and colleagues. https://lnkd.in/eeShN5Uj
28 November 2024
Look forward to, see you there?
28 October 2024
Where AI meets EEG biomarkers: Here we used AI/Deep-Learning trained to identify 'spindling excessive beta' activity, and could demonstrate this hypoarousal EEG signature is caused by sleep maintenance problems and is specifically linked to impulse control problems independent of DSM diagnosis. In addition, this signature was associated with ADHD diagnostic status in a sex-specific manner and predicted response to Sertraline in depression specif...
28 October 2024
Time to start with an EEG before TMS treatment! 18Hz and 20Hz TMS target a different MDD sub-population relative to 10Hz TMS, offering great potential to stratify patients based on individual alpha frequency using EEG. https://lnkd.in/ektK6QD9 This was a great collaboration, great thanks to BrainsWay and Abraham Zangen for sharing their dTMS 18Hz EEG data and Salience TMS Neuro Solutions, LLC, Jonathan Downar, Victoria Middleton for sharing th...
28 October 2024
Interessant 20 jarig jubileumcongres van NedKAD met veel interessante topics, van psychedelica, exposure therapie tot brain stimulation en onze bijdrage waarin we de vraag beantwoorden of we klaar zijn voor biomarkers in de klinische praktijk: Precisie Psychiatrie vs Stratified Psychiatrie.
29 September 2024
Screen use 2 hours before bedtime had no effect on total sleep duration, but it did delay sleep onset by an average of 10 minutes, with interactive screen use in bed being more harmful for sleep compared to passive screen use. With the growing prevalence of screen use among adolescents, especially before bedtime, its potential impact on sleep health has garnered increased attention. A recent study published in JAMA Pediatrics explored the associ...
29 September 2024
Net uit in TvP: De toepassing van rTMS bij dwangstoornissen in Nederland en België: consensusverklaring Bij dwangstoornissen (OCS) die niet voldoende reageren op gedragstherapie of medicatie was het enige (vergoede) alternatief diepe hersenstimulatie (DBS). In deze consensusverklaring adviseren we niet-invasieve hersenstimulatie (TMS) te overwegen voordat bij iemand DBS geïndiceerd is. https://lnkd.in/eEMRZfBh Congrats: Odile A. van den Heuvel...

Follow us: